Robert Lebuhn - Net Worth and Insider Trading

Robert Lebuhn Net Worth

The estimated net worth of Robert Lebuhn is at least $63,196 dollars as of 2024-11-13. Robert Lebuhn is the Director of Cambrex Corp and owns about 1,000 shares of Cambrex Corp (CBM) stock worth over $59,990. Robert Lebuhn is also the Director of Enzon Pharmaceuticals Inc and owns about 42,189 shares of Enzon Pharmaceuticals Inc (ENZN) stock worth over $3,206. Details can be seen in Robert Lebuhn's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Lebuhn has not made any transactions after 2013-09-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Robert Lebuhn

To

Robert Lebuhn Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Lebuhn owns 1 companies in total, including Enzon Pharmaceuticals Inc (ENZN) .

Click here to see the complete history of Robert Lebuhn’s form 4 insider trades.

Insider Ownership Summary of Robert Lebuhn

Ticker Comapny Transaction Date Type of Owner
ENZN Enzon Pharmaceuticals Inc 2013-09-19 director

Robert Lebuhn Latest Holdings Summary

Robert Lebuhn currently owns a total of 2 stocks. Among these stocks, Robert Lebuhn owns 1,000 shares of Cambrex Corp (CBM) as of February 25, 2005, with a value of $59,990 and a weighting of 94.93%. Robert Lebuhn also owns 42,189 shares of Enzon Pharmaceuticals Inc (ENZN) as of September 19, 2013, with a value of $3,206 and a weighting of 5.07%.

Latest Holdings of Robert Lebuhn

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CBM Cambrex Corp 2005-02-25 1,000 59.99 59,990
ENZN Enzon Pharmaceuticals Inc 2013-09-19 42,189 0.08 3,206

Holding Weightings of Robert Lebuhn


Robert Lebuhn Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert Lebuhn has made a total of 0 transactions in Cambrex Corp (CBM) over the past 5 years. The most-recent trade in Cambrex Corp is the sale of 1,100 shares on February 25, 2005, which brought Robert Lebuhn around $24,200.

According to the SEC Form 4 filings, Robert Lebuhn has made a total of 0 transactions in Enzon Pharmaceuticals Inc (ENZN) over the past 5 years. The most-recent trade in Enzon Pharmaceuticals Inc is the sale of 55,926 shares on September 19, 2013, which brought Robert Lebuhn around $96,193.

Insider Trading History of Robert Lebuhn

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert Lebuhn Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Robert Lebuhn Ownership Network

Ownership Network List of Robert Lebuhn

No Data

Ownership Network Relation of Robert Lebuhn

Insider Network Chart

Robert Lebuhn Owned Company Details

What does Enzon Pharmaceuticals Inc do?

Who are the key executives at Enzon Pharmaceuticals Inc?

Robert Lebuhn is the director of Enzon Pharmaceuticals Inc. Other key executives at Enzon Pharmaceuticals Inc include other: See Footnote 1 Family Fund Couchman , other: See explanation of responses Brian James Harper , and other: See explanation of responses Harper Asset Management Llc .

Enzon Pharmaceuticals Inc (ENZN) Insider Trades Summary

Over the past 18 months, Robert Lebuhn made no insider transaction in Enzon Pharmaceuticals Inc (ENZN). Other recent insider transactions involving Enzon Pharmaceuticals Inc (ENZN) include a net purchase of 99,550 shares made by Randolph C Read ,

In summary, during the past 3 months, insiders sold 0 shares of Enzon Pharmaceuticals Inc (ENZN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Enzon Pharmaceuticals Inc (ENZN) were sold and 99,550 shares were bought by its insiders, resulting in a net purchase of 99,550 shares.

Enzon Pharmaceuticals Inc (ENZN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Enzon Pharmaceuticals Inc Insider Transactions

No Available Data

Robert Lebuhn Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Lebuhn. You might contact Robert Lebuhn via mailing address: 222 S 15th Street, Suite 600 N, Omaha Ne 68102.